Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine
Clinical trial NCT00435812 · COMPLETED
Trial details
- NCT number
- NCT00435812
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-02-01
- Enrollment
- 2428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.